Precursor Cell Lymphoblastic Leukemia-Lymphoma
"Precursor Cell Lymphoblastic Leukemia-Lymphoma" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A neoplasm characterized by abnormalities of the lymphoid cell precursors leading to excessive lymphoblasts in the marrow and other organs. It is the most common cancer in children and accounts for the vast majority of all childhood leukemias.
MeSH Number(s)
C04.557.337.428.600
C15.604.515.560.600
C20.683.515.528.600
Concept/Terms
Precursor Cell Lymphoblastic Leukemia-Lymphoma- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Precursor Cell Lymphoblastic Leukemia Lymphoma
- Leukemia, Lymphoblastic
- Leukemia, Lymphoblastic, Acute
- Leukemia, Lymphocytic, Acute
- Lymphoma, Lymphoblastic
- Lymphoblastic Leukemia
- Lymphoblastic Leukemia, Acute
- Acute Lymphoblastic Leukemia
- Leukemia, Acute Lymphoblastic
- Lymphoblastic Lymphoma
- Lymphomas, Lymphoblastic
- Lymphocytic Leukemia, Acute
- Acute Lymphocytic Leukemia
- Leukemia, Acute Lymphocytic
- Acute Lymphoid Leukemia
- Leukemia, Acute Lymphoid
- Lymphoid Leukemia, Acute
- Leukemia, Lymphoid, Acute
Leukemia, Lymphocytic, Acute, L1- Leukemia, Lymphocytic, Acute, L1
- Lymphocytic Leukemia, L1
- L1 Lymphocytic Leukemia
- Leukemia, L1 Lymphocytic
- Lymphoblastic Leukemia, Acute, Childhood
- Lymphoblastic Leukemia, Acute, L1
- ALL, Childhood
- Childhood ALL
- Leukemia, Lymphoblastic, Acute, L1
Leukemia, Lymphocytic, Acute, L2- Leukemia, Lymphocytic, Acute, L2
- Lymphocytic Leukemia, L2
- L2 Lymphocytic Leukemia
- Leukemia, L2 Lymphocytic
- Lymphoblastic Leukemia, Acute, Adult
- Lymphoblastic Leukemia, Acute, L2
- Leukemia, Lymphoblastic, Acute, L2
- Leukemia, Lymphoblastic, Acute, Philadelphia-Positive
Below are MeSH descriptors whose meaning is more general than "Precursor Cell Lymphoblastic Leukemia-Lymphoma".
Below are MeSH descriptors whose meaning is more specific than "Precursor Cell Lymphoblastic Leukemia-Lymphoma".
This graph shows the total number of publications written about "Precursor Cell Lymphoblastic Leukemia-Lymphoma" by people in Harvard Catalyst Profiles by year, and whether "Precursor Cell Lymphoblastic Leukemia-Lymphoma" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1993 | 8 | 5 | 13 |
| 1994 | 12 | 2 | 14 |
| 1995 | 13 | 5 | 18 |
| 1996 | 12 | 2 | 14 |
| 1997 | 15 | 4 | 19 |
| 1998 | 11 | 2 | 13 |
| 1999 | 7 | 1 | 8 |
| 2000 | 12 | 2 | 14 |
| 2001 | 13 | 3 | 16 |
| 2002 | 11 | 3 | 14 |
| 2003 | 14 | 3 | 17 |
| 2004 | 14 | 2 | 16 |
| 2005 | 18 | 4 | 22 |
| 2006 | 17 | 6 | 23 |
| 2007 | 21 | 5 | 26 |
| 2008 | 11 | 11 | 22 |
| 2009 | 21 | 3 | 24 |
| 2010 | 20 | 5 | 25 |
| 2011 | 20 | 5 | 25 |
| 2012 | 21 | 2 | 23 |
| 2013 | 20 | 3 | 23 |
| 2014 | 28 | 3 | 31 |
| 2015 | 21 | 2 | 23 |
| 2016 | 35 | 5 | 40 |
| 2017 | 24 | 5 | 29 |
| 2018 | 29 | 0 | 29 |
| 2019 | 36 | 3 | 39 |
| 2020 | 41 | 2 | 43 |
| 2021 | 45 | 2 | 47 |
| 2022 | 39 | 1 | 40 |
| 2023 | 5 | 0 | 5 |
Below are the most recent publications written about "Precursor Cell Lymphoblastic Leukemia-Lymphoma" by people in Profiles.
-
A systems approach points to a therapeutic role for retinoids in asparaginase-associated pancreatitis. Sci Transl Med. 2023 Mar 15; 15(687):eabn2110.
-
PSEUDOPANUVEITIS AS A HARBINGER FOR SYSTEMIC LEUKEMIA RECURRENCE. Retin Cases Brief Rep. 2023 Mar 01; 17(2):117-119.
-
Recombinant Erwinia asparaginase (JZP458) in acute lymphoblastic leukemia: results from the phase 2/3 AALL1931 study. Blood. 2023 02 16; 141(7):704-712.
-
Impact of poverty and neighborhood opportunity on outcomes for children treated with CD19-directed CAR T-cell therapy. Blood. 2023 02 09; 141(6):609-619.
-
Racial and ethnic disparities in childhood and young adult acute lymphocytic leukaemia: secondary analyses of eight Children's Oncology Group cohort trials. Lancet Haematol. 2023 Feb; 10(2):e129-e141.
-
The impact of early PEG-asparaginase discontinuation in young adults with ALL: a post hoc analysis of the CALGB 10403 study. Blood Adv. 2023 01 24; 7(2):196-204.
-
Intensity of induction regimen and outcomes among adults with Ph+ALL undergoing allogeneic hematopoietic stem cell transplantation. Leuk Res. 2023 02; 125:107004.
-
ZNF384 rearrangement is the most frequent genetic lesion in adult PH-negative and Ph-like-negative B-other acute lymphoblastic leukemia. Biological and clinical findings. Leuk Lymphoma. 2023 02; 64(2):483-486.
-
Two-year follow-up of KTE-X19 in patients with relapsed or refractory adult B-cell acute lymphoblastic leukemia in ZUMA-3 and its contextualization with SCHOLAR-3, an external historical control study. J Hematol Oncol. 2022 12 10; 15(1):170.
-
X-linked inhibitor of apoptosis protein represents a promising therapeutic target for relapsed/refractory ALL. EMBO Mol Med. 2023 01 11; 15(1):e14557.